Asia Deal Watch: Chugai Teams With Rani On Oral Version Of Rare Disease Antibody Drug
Plus deals involving Astellas/Taysha, Haihe/Taiho, AimedBio/Boehringer Ingelheim, Takeda/Nabla, CytoMed/TC BioPharm, Specialised Therapeutics/CanariaBio, UgeneX/AviadoBio, Lupin, Kissei/Searchlight, Kazia/QIMR and Prism/Servier.
Scrip - October 17, 2025

Biopharma Has Been Fast To Adopt AI/ML, But It’s Unclear How It Will Play Out
One panelist at the BioFuture conference said AI is a bubble, but that when the bubble bursts it will leave a lot of innovation in its wake.
Scrip - October 17, 2025

Roche Ready To File First-In-Class Eye Drug Despite Mixed Phase III Results
The company will ask regulators to consider the totality of the data for vamikibart and look past the failure of one of its Phase III trials
Scrip - October 17, 2025

CDER Director Sows Doubt US FDA Will Move Away From UV Filter Animal Tests
Center for Drug Evaluation and Research Director George Tidmarsh emphasizes the reduction, but not necessarily the elimination, of animal tests for UV filters in an FDA Voices post, raising questions about the agency’s intentions.
HBW Insight - October 17, 2025

Medicare’s TCET Pathway Wins Acclaim From Early Users, Even As ‘Messy Middle’ Persists
Some of the first manufacturers to receive Medicare coverage for their breakthrough devices through the Transitional Coverage for Emerging Technologies pathway praise CMS’ engagement and timelines in the process, despite some challenges around post-launch data collection.
Medtech Insight - October 17, 2025

German OTC Market: Cough & Cold Launches From P&G, Angelini And Zentiva
P&G expands its WICK range with a new natural line of cough syrups; Angelini introduces a guideline-compliant Tantum Verde Duo throat spray; Zentiva adds a children’s fever product to its Ibuflam brand.
HBW Insight - October 17, 2025

Archimed Acquires Denmark’s DermaPharm To Broaden Skin Care Offering
A rising demand for eco-certified skin care products attracted Archimed to invest in Denmark's DermaPharm, which markets the Avivir and DermaKnowlogy brands.
HBW Insight - October 17, 2025

Adalvo: Exploring European B2B Pharma’s Next Steps
Listen now as Citeline speaks with Anil Okay, CEO of Europe’s fast-growing pharma B2B, Adalvo. Learn what the company’s recent acquisition by private equity firm EQT means for both Adalvo and for the industry at large, and find out what trends will be fueling pharma in the years ahead.
Scrip - October 17, 2025

Pressure On Novavax Could Mount As Shah Capital’s Push For Sale Draws Support
The vocal shareholder tells Scrip that other investors have reached out supporting its push for a sale of the vaccine maker.
Scrip - October 17, 2025

Adalvo: Interview With CEO Anil Okay
Watch now as Adalvo CEO Anil Okay shares with Citeline his perspectives on the rapidly-growing European B2B’s recent acquisition by private equity firm EQT. Find out what it means for the business, and how it may reflect wider pharma trends, in this insightful video interview.
Generics Bulletin - October 17, 2025

Zimmer Biomet-Monogram Merger: After Clearances, First CVR Milestone Approaching In January 2026
After a slight delay in closing the deal, Zimmer now has Monogram in-house. For shareholders hoping for CVR payouts, the first one looks fairly achievable, the rest increasingly less so. The vagaries of FDA clearance and market performance offer significant challenges to the new robotics powerhouse.
Medtech Insight - October 17, 2025

Formycon Secures Two Partners In Australia And Latin America For Eylea Biosimilar
Formycon and its aflibercept biosimilar partner Klinge shook hands with Actor Pharmaceuticals and Megalabs to market the Eylea rival in their respective regions.
Generics Bulletin - October 17, 2025

Pipeline Watch: Two Approvals And Nine Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Scrip - October 17, 2025

German Medtechs Choking Under EU Compliance And Reporting Obligations Tout Mutual Recognition
Industry survey points to ongoing low revenues rise and weaker profit levels for half of BVMed industry association members in 2025, as German manufacturers raise stakes on global harmonization.
Medtech Insight - October 17, 2025

‘Lessons Have Not Been Learned’ On UWWTD Ahead Of Fresh Study By EU Commission
As the European Commission prepares to publish its latest study on the Urban Waste Water Treatment Directive, industry leaders have bemoaned a lack of consultation and have suggested that a simple update of existing cost estimates should be replaced by a more thorough impact assessment.
Generics Bulletin - October 17, 2025

Sandoz Says UK Should Prioritize Uptake And Competition Over Rebates
While branded generics and biosimilars remain subject to the UK’s VPAG pricing scheme, Sandoz’s public affairs lead has argued that focusing on driving competition and uptake rather than rebates is a better way to generate savings – and that off-patent products should be exempt from VPAG altogether.
Generics Bulletin - October 17, 2025

Hansoh/Roche ADC Deal Caps Chinese One-Day Licensing Spree
Multiple Chinese biopharma firms reach new deals with major Western and other partners in a spree of licensing deals over a one-day period, with ADCs, in vivo CAR and bifunctional fusion protein therapies among the target assets.
Scrip - October 17, 2025

Abbott Eyes Strong US Diabetes Growth In 2026, Diagnostics Recovery As China Headwinds Ease
Abbott CEO Robert Ford said the diagnostics segment – pressured this year by China’s VBP and DRG reforms – is showing early signs of recovery, while the company’s operations in the US, Europe, and Latin America continue to grow at a healthy pace.
Medtech Insight - October 17, 2025

Viatris Looks To Expand Japan Presence With Aculys Acquisition
Global generics-focused giant acquires Japanese venture with late-stage, two-asset CNS pipeline as it looks to build presence in Japan.
Scrip - October 17, 2025